Uterine fibroids in women are closely related to the levels of estrogen in the body. Some women have relatively small uterine fibroids with no clinical symptoms and can be observed dynamically. Generally, after menopause, when the levels of estrogen decrease, the size of uterine fibroids in these women can naturally shrink. Additionally, certain medications can be used for treatment, such as drugs from the GnRH-a class, which act by causing ovarian ablation. This leads to a decrease in estrogen levels in the body and can also reduce the size of the uterine fibroids. Interventional treatments can also be employed to block the blood supply to the uterine fibroids, reducing their blood supply and consequently decreasing their size.